Company intelligence / Profile preview

Eunoe

Palm Beach, Florida, United Statesfacebook.com ↗

Ownership: Private
Employees: ~1
Development stage: Phase 2

Overview

Eunoe developed innovative medical devices with a focus on neurological conditions such as Alzheimer’s disease. The company attracted notable investment ($40M in 2003), achieved key product development milestones, and gained attention for its contributions to the medical device industry before its intellectual property estate was acquired by Integra LifeSciences in 2005. No specific published clinical results are available.

Therapeutic areas: Neurology
Modalities: Device-based therapyMedical devices
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

COGNIShunt

Phase 2

Indications: Alzheimer's disease

Beyond the preview

Go deeper on Eunoe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eunoe.

Explore the full profile